Literature DB >> 10494581

Long-term effects of prenatal 3'-azido-3'-deoxythymidine (AZT) exposure on intermale aggressive behaviour of mice.

C Rondinini1, A Venerosi, I Branchi, G Calamandrei, E Alleva.   

Abstract

RATIONALE: AZT treatment of seropositive pregnant women and their neonates has been widely used due to its effectiveness in reducing vertical transmission of HIV, but medium- and long-term effects of AZT on neurobehavioural development and adult responding are still poorly described.
OBJECTIVE: The aim of the present study was to evaluate the long-term effects of prenatal AZT treatment on aggressive behaviour of adult male mice.
METHODS: Pregnant CD-1 mice were given saline vehicle, 0.4, or 0.8 mg/ml AZT in their drinking water from gestation day 10 to delivery. Social-aggressive types of interaction were assessed in their male offspring following a 4-week isolation period. Two groups of subjects were used, each undergoing a different type of test: test 1 consisted of a single 20-min encounter with an isolated same-strain opponent on postnatal day (PND) 90, while in test 2 (PND 150) subjects were paired for 10 min for 5 consecutive days with a non-isolated opponent.
RESULTS: Slight changes in both aggressive and defensive components of the male-specific agonistic pattern were evident only in test 1, AZT mice displaying a limited increase of aggressive behaviour compared to their controls.
CONCLUSIONS: Although the long-term effects of prenatal AZT on social behaviour are limited, they may be of some relevance for paediatricians in order to plan a follow-up of infants, children and adolescents exposed in utero to antiretroviral drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10494581     DOI: 10.1007/s002130051064

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  5 in total

Review 1.  Antiretroviral therapy in pregnancy: a focus on safety.

Authors:  G P Taylor; N Low-Beer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.

Authors:  Patricia A Sirois; Yanling Huo; Paige L Williams; Kathleen Malee; Patricia A Garvie; Betsy Kammerer; Kenneth Rich; Russell B Van Dyke; Molly L Nozyce
Journal:  Pediatr Infect Dis J       Date:  2013-06       Impact factor: 2.129

3.  Neurotoxic effects of AZT on developing and adult neurogenesis.

Authors:  Meryem Demir; Eric D Laywell
Journal:  Front Neurosci       Date:  2015-03-20       Impact factor: 4.677

4.  In utero exposure to HIV and/or antiretroviral therapy: a systematic review of preclinical and clinical evidence of cognitive outcomes.

Authors:  Megan S McHenry; Kayode A Balogun; Brenna C McDonald; Rachel C Vreeman; Elizabeth C Whipple; Lena Serghides
Journal:  J Int AIDS Soc       Date:  2019-04       Impact factor: 6.707

5.  Transplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine.

Authors:  Anna Rita Zuena; Chiara Giuli; Aldina Venerosi Pesciolini; Antonella Tramutola; Maria Antonietta Ajmone-Cat; Carlo Cinque; Giovanni Sebastiano Alemà; Angela Giovine; Gianfranco Peluso; Luisa Minghetti; Raffaella Nicolai; Gemma Calamandrei; Paola Casolini
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.